FPN || Gastroenterology

Vary CRC screening by age, sex, race, ethnicity?

Posted on: 01/08/2014 - 05:01

Among adults at average risk for colorectal cancer who undergo screening colonoscopy, the yield of large polyps and tumors varies widely by patient age, sex, race, and ethnicity. This means that an...

Field of Interest: Gastroentero...
Type: News Item

Emergency physicians may be overprescribing PPIs

Posted on: 23/07/2014 - 21:00

DALLAS – The frequency at which U.S. emergency department physicians prescribed proton pump inhibitors more than doubled during 2001-2010, despite mounting safety concerns surrounding this class of...

Field of Interest: Gastroentero...
Type: News Item

Birth defect risk low in celiac disease

Posted on: 01/07/2014 - 05:01

Pregnant mothers with celiac disease have little to fear when it comes to birth defects, despite previous underpowered reports to the contrary, wrote Daniela Zugna, Ph.D., and her colleagues in the...

Field of Interest: Gastroentero...
Type: News Item

Birth defect risk low in celiac disease

Posted on: 01/07/2014 - 05:01

Pregnant mothers with celiac disease have little to fear when it comes to birth defects, despite previous underpowered reports to the contrary, wrote Daniela Zugna, Ph.D., and her colleagues in the...

Field of Interest: Pulmonology
Type: News Item

Intervention ups annual FOBT screening to 82%

Posted on: 16/06/2014 - 21:00

An inexpensive telephone intervention raised the rate of annual colorectal cancer screening using fecal occult blood testing to 82% in an underserved population at particular risk for poor health,...

Field of Interest: Gastroentero...
Type: News Item

Intervention ups annual FOBT screening to 82%

Posted on: 16/06/2014 - 21:00

An inexpensive telephone intervention raised the rate of annual colorectal cancer screening using fecal occult blood testing to 82% in an underserved population at particular risk for poor health,...

Field of Interest: Oncology
Type: News Item

Mesalazine didn’t help diarrhea-predominant IBS

Posted on: 10/06/2014 - 19:40

CHICAGO – Treating diarrhea-predominant irritable bowel syndrome with mesalazine for 12 weeks failed to improve stool frequency or other symptoms, compared with placebo, in a multicenter, randomized...

Field of Interest: Gastroentero...
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More